Leveraging AI for Sustainable Drug Commercialization and Advanced Therapy Management in TVET Innovations in Cell and Gene Therapy and Patient Support

Abstract

The integration of Artificial Intelligence (AI) in Technical and Vocational Education and Training (TVET) is transforming the landscape of drug commercialization, advanced therapy management, and patient support services. This chapter explores how AI-driven solutions are enhancing the development, production, and distribution of cell and gene therapies, ensuring sustainability and efficiency in the healthcare sector. It delves into the role of AI in optimizing clinical trials, regulatory compliance, and supply chain logistics, addressing challenges in cost, accessibility, and scalability. Additionally, the chapter examines how AI-powered patient support services, such as predictive analytics, personalized treatment monitoring, and virtual healthcare assistance, are improving patient adherence and outcomes. By integrating AI within TVET curricula, future professionals can gain the necessary skills to navigate the evolving pharmaceutical and biotechnology industries, fostering a sustainable and innovative healthcare ecosystem.

Ähnliche Arbeiten